BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2021 5:19:47 AM | Browse: 499 | Download: 1333
 |
Received |
|
2021-03-24 12:41 |
|
Peer-Review Started |
|
2021-03-24 12:42 |
|
First Decision by Editorial Office Director |
|
2021-06-16 14:22 |
|
Return for Revision |
|
2021-06-16 14:22 |
|
Revised |
|
2021-06-17 15:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-18 03:16 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-18 06:56 |
|
Articles in Press |
|
2021-08-18 06:56 |
|
Edit the Manuscript by Language Editor |
|
2021-08-27 01:05 |
|
Typeset the Manuscript |
|
2021-10-12 06:04 |
|
Publish the Manuscript Online |
|
2021-10-14 05:19 |
| ISSN |
2218-5836 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Orthopedics |
| Manuscript Type |
Case Control Study |
| Article Title |
SARS-CoV-2 outbreak impact on a trauma unit
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sarah Mills, Aitor Ibarzábal-Gil, José M Martínez-Diez, Javier Pallarés-Sanmartín, Carlos Kalbakdij-Sánchez, Juan C Rubio-Suárez, Itsaso Losantos-García and E Carlos Rodríguez-Merchán |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
E Carlos Rodríguez-Merchán, MD, PhD, Doctor, Doctor, Department of Orthopedic Surgery, La Paz University Hospital, Paseo de la Castellana, 261, Madrid 28046, Spain. ecrmerchan@hotmail.com |
| Key Words |
Trauma department; COVID-19 pandemic; SARS-CoV-2 outbreak; Hip fractures; Morbimortality; Polytraumatic patients |
| Core Tip |
Coronavirus severe acute respiratory syndrome-2 (SARS-CoV-2) infection was not a criterion for choosing conservative treatment, unless those patients infected with the virus had a poor general condition that made surgery unadvisable. We did not find a relationship between the employment of anticoagulant therapy and the severity of coronavirus disease 2019 (COVID-19) infection or a different mortality rate. Patients who died during hospitalization due to COVID-19 had higher C-reactive protein levels (P < 0.001) and higher urea levels (P = 0.006). The mortality rate in 2020 was 13.7% during hospitalization; 19% during the first month after discharge and 24.6% in the three months after discharge. The mortality rate in the COVID-19 positive patients subgroup was 38.9% after 6 mo of follow-up. Non-operative treatment in hip fractures was related to SARS-CoV-2 infection (P = 0.03) and with AO 31.B fractures. Polytrauma patients and high energy fractures were more common in 2019 (24%) than in 2020 (11.5%). The main difference between both periods was the injury mechanism. |
| Publish Date |
2021-10-14 05:19 |
| Citation |
Mills S, Ibarzábal-Gil A, Martínez-Diez JM, Pallarés-Sanmartín J, Kalbakdij-Sánchez C, Rubio-Suárez JC, Losantos-García I, Rodríguez-Merchán EC. SARS-CoV-2 outbreak impact on a trauma unit. World J Orthop 2021; 12(10): 751-759 |
| URL |
https://www.wjgnet.com/2218-5836/full/v12/i10/751.htm |
| DOI |
https://dx.doi.org/10.5312/wjo.v12.i10.751 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
